Genomic Heterogeneity of Pancreatic Ductal Adenocarcinoma and Its Clinical Impact

Volume: 13, Issue: 17, Pages: 4451 - 4451
Published: Sep 3, 2021
Abstract
Pancreatic ductal adenocarcinoma (PDAC) is one of the leading causes of cancer death due to limited advances in recent years in early diagnosis and personalized therapy capable of overcoming tumor resistance to chemotherapy. In the last decades, significant advances have been achieved in the identification of recurrent genetic and molecular alterations of PDAC including those involving the KRAS, CDKN2A, SMAD4, and TP53 driver genes. Despite...
Paper Details
Title
Genomic Heterogeneity of Pancreatic Ductal Adenocarcinoma and Its Clinical Impact
Published Date
Sep 3, 2021
Journal
Volume
13
Issue
17
Pages
4451 - 4451
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.